Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ·Healthcare·Biotechnology
$14.78
-3.34%
Mkt Cap $1.34B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | — | — | — | -$0.51 | -$0.50 | +1.96% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.44 | -$0.49 | -11.36% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.43 | -$0.51 | -18.60% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.49 | -$0.36 | +26.53% | — | — |
| Q1 2025 Mar 18, 2025 | — | — | — | -$0.63 | -$0.51 | +19.05% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.59 | -$0.60 | -1.69% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.54 | -$0.54 | +0.00% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.53 | -$0.56 | -5.66% | — | — |
| Q1 2024 Mar 11, 2024 | — | $1.88M | — | -$0.49 | -$0.49 | +0.00% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.51 | -$0.48 | +5.88% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.73 | -$0.49 | +32.88% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.66 | -$0.70 | -6.06% | — | — |
| Q1 2023 Mar 9, 2023 | — | — | — | -$0.65 | -$0.65 | +0.00% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.79 | -$0.57 | +27.85% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.65 | -$0.82 | -26.15% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$0.57 | -$0.58 | -1.75% | — | — |
| Q1 2022 Feb 28, 2022 | — | — | — | -$0.51 | -$0.54 | -5.88% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$0.47 | -$0.45 | +4.26% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$0.39 | -$0.42 | -7.69% | — | — |
| Q2 2021 May 11, 2021 | — | — | — | -$0.28 | -$0.39 | -39.29% | — | — |